Schedule-dependent interaction between paclitaxel and doxorubicin in human cancer cell lines in vitro
- 31 December 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (13-14) , 2341-2346
- https://doi.org/10.1016/0959-8049(95)00448-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Taxol in combination with doxorubicin or etoposide possible antagonism in vitroCancer, 1993
- An overview of experience with taxol∗ (paclitaxel) in the U.S.ACancer Treatment Reviews, 1993
- Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-Cell Viability AssayBreast Cancer Research and Treatment, 1993
- TaxolAnti-Cancer Drugs, 1992
- Effects of amsacrine in combination with other anticancer agents in human acute lymphoblastic leukemia cells in cultureLeukemia Research, 1991
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Taxol assembles tubulin in the absence of exogenous guanosine 5'-triphosphate or microtubule-associated proteinsBiochemistry, 1981
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivityInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971